TITLE

Liver cells in vitro could save patients in vivo

AUTHOR(S)
Davies, Anne
PUB. DATE
November 1991
SOURCE
New Scientist;11/23/91, Vol. 132 Issue 1796, p26
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Announces that U.S. surgeons are using live cells in an artificial liver that could act as a temporary short-term support system outside the body for patients with liver failure. Description of a bioreactor used in the technique; Aim of the inventors led by Frank Cerra, a professor of surgery at the University of Minnesota, to use an enlarged version of the artificial liver on humans.
ACCESSION #
10557642

 

Related Articles

  • Artificial support systems for liver failure. Berk, Paul D.; Scharschmidt, Bruce F.; Martin, James F.; Plotz, Paul H. // Kidney International Supplement;Dec1976, Issue 7, p233 

    Presents a study which focus on artificial support systems for liver failure. Similarities in the role and function of the liver and kidneys; Examination on the necessary characteristics of an artificial device to perform the essential, life-saving functions of the failing liver; Proposal of...

  • Progress in technology and clinical application of non - bioartificial liver support system. LIU Xiaohui; GUO Haiqing; ZHANG Jing // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;sep2013, Vol. 29 Issue 9, p661 

    Several types of non - bioartificial liver support systems are now widely used in the treatment of severe hepatitis and liver failure, which are life - threatening diseases, but no consensus has been reached regarding its efficacy. The designs and results of high - level studies for evaluating...

  • Observation and Nursing Care in Treatment of Hepatic Failure Complications with MARS Artificial Liver. WANG Hong-yue; LANG Lang // Journal of Kunming Medical University / Kunming Yike Daxue Xueba;2014, Vol. 35 Issue 12, p178 

    Objective To discuss the prevention and nursing of MARS artificial liver in the treatment of hepatic failure complications. Method We retrospectively analyzed 162 cases of hepatic failure complications, all of them were treated with MARS artificial liver. Result Complications were found in 148...

  • Investigation of artificial liver support system combined with stem cell transplantation in treatment of liver failure. HE Hongliang; LI Jianguo; GAO Zhiliang // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;sep2013, Vol. 29 Issue 9, p670 

    Currently, the main treatment strategies for liver failure include comprehensive medical treatment, artificial liver support system treatment, liver transplantation, and stem cell transplantation. In recent years, major progress has been made in liver failure treatment with artificial liver...

  • Clinical Use of a Bioartificial Liver in the Treatment of Acetaminophen-Induced... Detry, Olivier; Arkadopoulos, Nikolaos // American Surgeon;Oct1999, Vol. 65 Issue 10, p934 

    Patients with acetaminophen-induced fulminant hepatic failure (FHF) who meet the King's College Hospital criteria have a high mortality risk (>90%) if they do not undergo liver transplantation. We have developed a treatment strategy for these patients based on the use of an extracorporeal...

  • Development of a bioreactor based on magnetically stabilized fluidized bed for bioartificial liver. Deng, Fei; Chen, Li; Zhang, Ying; Zhao, Shan; Wang, Yu; Li, Na; Li, Shen; Guo, Xin; Ma, Xiaojun // Bioprocess & Biosystems Engineering;Dec2015, Vol. 38 Issue 12, p2369 

    Bioartificial liver (BAL) based on microcapsules has been proposed as a potential treatment for acute liver failure. The bioreactors used in such BAL are usually expected to achieve sufficient flow rate and minimized void volume for effective application. Due to the superiorities in bed pressure...

  • Evaluation of Encapsulated Liver Cell Spheroids in a Fluidised-Bed Bioartificial Liver for Treatment of Ischaemic Acute Liver Failure in Pigs in a Translational Setting. Selden, Clare; Spearman, Catherine Wendy; Kahn, Delawir; Miller, Malcolm; Figaji, Anthony; Erro, Eloy; Bundy, James; Massie, Isobel; Chalmers, Sherri-Ann; Arendse, Hiram; Gautier, Aude; Sharratt, Peter; Fuller, Barry; Hodgson, Humphrey // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Liver failure is an increasing problem. Donor-organ shortage results in patients dying before receiving a transplant. Since the liver can regenerate, alternative therapies providing temporary liver-support are sought. A bioartificial-liver would temporarily substitute function in liver failure...

  • Advances in Extracorporeal Detoxification by MARS Dialysis in Patients with Liver Failure. Di Campli, C.; Dal Verme, L. Zileri; Andrisani, M.C.; Armuzzi, A.; Candelli, M.; Gaspari, R.; Gasbarrini, A. // Current Medicinal Chemistry;Feb2003, Vol. 10 Issue 4, p341 

    Although liver transplantation has become standard procedure for patients with liver failure, a number of issues in the management of these patients remains to be addressed. Alternative approaches have been tested, such as hepatocytes containing liver-support systems and filtration devices....

  • VITAGEN ANNOUNCES ENROLLMENT FOR PHASE II TRIAL OF ELAD(r) BIOARTIFICIAL LIVER SUPPORT THERAPY. Stern, Aron // Internet Journal of Mental Health;2002, Vol. 1 Issue 2, p68 

    The article focuses on a first human cell-based bioartificial liver system designed to increase the liver's ability to regenerate and recover. VitaGen Inc. announced about the enrolling of patients with fulminant hepatic failure (FHF) in a multicenter Phase II clinical trial. These patients...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics